Alterations in serum anti-α-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis

Clinical Immunology

Volumn 103, Issue 1, 2002, Pages 63-68

  D'Alessandro, Mariadomenica ^a   Mariani, Paola ^a   Lomanto, Davide ^a   Bachetoni, Alessandra ^a   Speranza, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti Gal antibodies; Inflammatory bowel disease; Intestinal bacteria

Indexed keywords

ANTIBODY; CORTICOSTEROID; DISACCHARIDE; EPITOPE; GALACTOSYLGALACTOSE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0036251050     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5180     Document Type: Article

References (45)

1. A unique natural human IgG antibody with anti-α-galactosyl specificity
2. Man, apes and Old World monkeys differ from other mammalians in the expression of α-galactosyl epitopes on nucleated cells
3. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody
4. Anti-alpha-galactosyl immunoglobulin A, IgG, and IgM in human secretions
5. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of human flora
6. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces
7. The natural anti-α-galactosyl IgG on human normal senescent red blood cells
8. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody
9. Xenogenic transplantation
10. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans
11. Immunogenic Gal-α1-3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania
12. Complement mediated lysis of Tripanosoma cruzi trypomastigotes by human anti α-galactosyl antibodies
13. Naturally occurring anti α-galactosyl antibodies in human Plasmodium falciparum infections - A possible role for autoantibodies in malaria
14. Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (α1-3) galactose epitopes
15. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum
16. Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schonlein purpura or IgA nephropathy
17. Blood group isoantibody stimulation in man by feeding blood group-active bacteria
18. Structural studies on the hexoge region of the core lipolysaccharides from enterobacteriaceae
19. The immunohistochemistry of Salmonella chemotype VI O-antigen. The structure of oligosaccharides from Salmonella group U 043 lipopolysaccharides
20. Structural studies on Klebsiella O group 1 and 6 lipolysaccharides
21. Immune events associated with inflammatory bowel disease
22. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation
23. The genetics of inflammatory bowel disease: Genetic predispositions, disease markers and genetic heterogeneity
24. Alterations of IgM, IgG and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease
25. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities
26. Antibody (IgG, IgA, and IGM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease
27. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn's disease?
28. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens
29. Immunological studies in ulcerative colitis. Antibodies to colon antigen in patients with ulcerative colitis, Crohn disease and other diseases
30. Mucosal antibodies in inflammatory bowel disease are direct against intestinal bacteria
31. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens witin inflammatory bowel disease tissues
32. A human antibody binds to α-galactose receptors and mimics the effects of Clostridium difficile Toxin A in rat colon
33. Intestinal permeability and the predictor of relapse in Crohn's disease
34. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
35. Role of the intestinal microflora in pathogenesis and complications
36. Remission of Crohn's disease after human immunodeficiency virus infection
37. Crohn's disease stable remission after human immunodeficiency virus infection
38. Intestinal permeability: An overview
39. The prevalence of gut translocation in humans
40. Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease
41. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polirazed fashion
42. Monocyte/macrophage activation by normal bacteria and bacterial products
43. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
44. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
45. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations